Bone sarcoma characteristics and distribution in beagles injected with radium-226.
A total of 155 primary bone sarcomas were found in 131 of the 246 beagles injected with 226Ra and 5 primary bone sarcomas were found in 4 of the 158 unexposed controls. Of these 155 bone sarcomas, 146 (94%) were osteosarcomas and 9 were non-osteosarcomas. An additional 31 primary bone sarcomas (28 osteosarcomas) developed in 44 dogs terminated from the main study because of limb amputation for bone sarcoma. Non-osteosarcomas predominated in both the controls and the second lowest of six logarithmically increasing dose levels (there were no bone sarcomas in the lowest dose group). Osteosarcomas predominated at the higher dose levels, and incidence tended to increase as dose increased. The 146 osteosarcomas were distributed quite evenly between males and females (72:74). Of the 9 non-osteosarcomas, 6 occurred in males and 3 in females. The ratio of bone sarcomas of the appendicular skeleton to those in the axial skeleton was 110:45, with osteosarcomas occurring more often in the appendicular skeleton (108:38). Cases of multiple primary bone sarcomas in dogs injected with 226Ra were found only in the four highest dose groups. Amputations were performed on 44 of the 96 dogs (94 injected and 2 unexposed) that developed appendicular bone sarcomas. A statistical study of the distribution of bone sarcomas among 16 separate bone groups showed a statistically significant correlation to cancellous skeletal surface, but the variability among bone groups was too large for this relationship to be of real predictive value. It is postulated that the distribution of bone sarcomas reflects primarily the relative cell division rates in the bone groups and secondarily the radiation dose distribution, with the highest occurrence of bone sarcoma in the humeri, pelvis, femora and tibiae/fibular tarsal, and no occurrence in the coccygeal vertebrae, sternum, forepaws or hindpaws.
White
R G
RG
Laboratory for Energy-Related Health Research (LEHR), University of California, Davis 95616.
Raabe
O G
OG
Culbertson
M R
MR
Parks
N J
NJ
Samuels
S J
SJ
Rosenblatt
L S
LS
D000818:Animals; D001859:Bone Neoplasms / Q000209:etiology* / Q000401:mortality / Q000556:secondary; D015331:Cohort Studies; D004285:Dogs; D004307:Dose-Response Relationship, Radiation; D005260:Female; D015994:Incidence; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology / Q000209:etiology; D009381:Neoplasms, Radiation-Induced / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D012516:Osteosarcoma / Q000209:etiology* / Q000401:mortality / Q000556:secondary; D011883:Radium / Q000633:toxicity*
D011883:Radium